Scholars Central

EditorialPublished 2013

Drug Combinations in Cancer Treatments

Authors: Da-Yong Lu, Ting-Ren Lu, Shan Cao

Advances in Pharmacoepidemiology and Drug Safety

Volume 2 · Issue 5 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Most cancers have multiple genetic alterations or abnormalities. It is seldom very useful by only using one anticancer drug. Human cancer is a refractory and resistant disease, and like HIV virus, it might need anticancer drug cocktail, instead single drugs to dramatically control the progresses of the disease. Anticancer drug cocktail might be one of the good solutions for anticancer chemotherapy. How to combine use of anticancer drugs is a new problem and area of anticancer drug therapy. This editorial addresses this problem in depth.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Advances in Pharmacoepidemiology and Drug Safety.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAdvances in Pharmacoepidemiology and Drug Safety
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Da-Yong Lu”
  • BylineArticles whose byline prints “Ting-Ren Lu”
  • BylineArticles whose byline prints “Shan Cao”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels